Inovio Pharmaceuticals Inc INO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:48 PM EDT
2.38UNCH (UNCH)
Volume
59,079
Close
2.38quote price arrow down-0.13 (-5.18%)
Volume
4,111,226
52 week range
1.38 - 9.59
Loading...
  • Open2.46
  • Day High2.54
  • Day Low2.36
  • Prev Close2.51
  • 52 Week High9.59
  • 52 Week High Date08/26/21
  • 52 Week Low1.38
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap593.57M
  • Shares Out249.40M
  • 10 Day Average Volume6.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.93
  • YTD % Change-52.3

KEY STATS

  • Open2.46
  • Day High2.54
  • Day Low2.36
  • Prev Close2.51
  • 52 Week High9.59
  • 52 Week High Date08/26/21
  • 52 Week Low1.38
  • 52 Week Low Date06/16/22
  • Market Cap593.57M
  • Shares Out249.40M
  • 10 Day Average Volume6.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.93
  • YTD % Change-52.3

RATIOS/PROFITABILITY

  • EPS (TTM)-1.61
  • P/E (TTM)-1.48
  • Fwd P/E (NTM)-2.06
  • EBITDA (TTM)-337.272M
  • ROE (TTM)-87.99%
  • Revenue (TTM)2.11M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-16,673.32%
  • Debt To Equity (MRQ)5.55%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inovio Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Inovio Pharmaceuticals, Inc. (INOVIO) is a biotechnology company. The Company is focused on bringing to market designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus (HPV). Its DNA medicines pipeline consists of three types of product candidates, namely prophylactic DNA vaccines, therapeutic DNA immunotherapies...
Jacqueline Shea Ph.D.
President, Chief Executive Officer, Director
Peter Kies
Chief Financial Officer
Robert Crotty J.D.
General Counsel
Address
6769 Mesa Ridge Rd.
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
AUTL
Autolus Therapeutics PLC
3.34-0.25-6.96%
KOD
Kodiak Sciences Inc
10.46-0.93-8.17%
AVTE
Aerovate Therapeutics Inc
21.33-0.58-2.65%
DYN
Dyne Therapeutics Inc
11.50-0.76-6.20%
CGEM
Cullinan Oncology Inc
13.16-0.05-0.38%